Single-cell sequencing reveals the features of adaptive immune responses in the liver of a mouse model of dengue fever

Abstract

Background: Dengue fever, an acute insect-borne infectious disease caused by the dengue virus (DENV), poses a great challenge to global public health. Hepatic involvement is the most common complication of severe dengue and is closely related to the occurrence and development of disease. However, the features of adaptive immune responses associated with liver injury in severe dengue are not clear.

Methods: We used single-cell sequencing to examine the liver tissues of mild or severe dengue mice model to analyze the changes in immune response of T cells in the liver after dengue virus infection, and the immune interaction between macrophages and T cells. Flow cytometry was used to detect T cells and macrophages in mouse liver and blood to verify the single-cell sequencing results.

Results: Our result showed CTLs were significantly activated in the severe liver injury group but the immune function-related signal pathway was down-regulated. The reason may be that the excessive immune response in the severe group at the late stage of DENV infection induces the polarization of macrophages into M2 type, and the macrophages then inhibit T cell immunity through the TGF-β signaling pathway. In addition, the increased proportion of Treg cells suggested that Th17/Treg homeostasis was disrupted in the livers of severe liver injury mice.

Conclusions: In this study, single-cell sequencing and flow cytometry revealed the characteristic changes of T cell immune response and the role of macrophages in the liver of severe dengue fever mice. Our study provides a better understanding of the pathogenesis of liver injury in dengue fever patients.

Keywords

adaptive immunity / dengue fever model / liver injury / single-cell sequencing

References

[1] Robinson ML, Glass DR, Duran V, et al. Magnitude and kinetics of the human immune cell response associated with severe dengue progression by single-cell proteomics. Sci Adv. 2023;9(12):eade7702.

[2] Dengue worldwide over. 2024. Accessed February 17, 2024. https://www.ecdc.europa.eu/en/dengue-monthly

[3] Vasikasin V, Rojdumrongrattana T, Chuerboonchai W, et al. Effect of standard dose paracetamol versus placebo as antipyretic therapy on liver injury in adult dengue infection: a multicentre randomised controlled trial. Lancet Glob Health. 2019;7(5):e664-e670.

[4] Wong PF, Wong LP, AbuBakar S. Diagnosis of severe dengue: challenges, needs and opportunities. J Infect Public Health. 2020;13(2):193-198.

[5] Chia PY, Thein TL, Ong SWX, Lye DC, Leo YS. Severe dengue and liver involvement: an overview and review of the literature. Expert Rev Anti-Infect Ther. 2020;18(3):181-189.

[6] Teerasarntipan T, Chaiteerakij R, Komolmit P, Tangkijvanich P, Treeprasertsuk S. Acute liver failure and death predictors in patients with dengue-induced severe hepatitis. World J Gastroenterol. 2020;26(33):4983-4995.

[7] Leowattana W, Leowattana T. Dengue hemorrhagic fever and the liver. World J Hepatol. 2021;13(12):1968-1976.

[8] Póvoa TF, Alves AMB, Oliveira CAB, Nuovo GJ, Chagas VLA, Paes MV. The pathology of severe dengue in multiple organs of human fatal es: histopathology, ultrastructure and virus replication. PLoS ONE. 2014;9(4):e83386.

[9] Aye KS, Charngkaew K, Win N, et al. Pathologic highlights of dengue hemorrhagic fever in 13 autopsy es from Myanmar. Hum Pathol. 2014;45(6):1221-1233.

[10] Heymann F, Tacke F. Immunology in the liver—from homeostasis to disease. Nat Rev Gastroenterol Hepatol. 2016;13(2):88-110.

[11] Thimme R. T cell immunity to hepatitis C virus: lessons for a prophylactic vaccine. J Hepatol. 2021;74(1):220-229.

[12] Kemming J, Thimme R, Neumann-Haefelin C. Adaptive Immune Response against Hepatitis C Virus. Int J Mol Sci. 2020;21(16):5644.

[13] Drescher HK, Bartsch LM, Weiskirchen S, Weiskirchen R. Intrahepatic TH17/TReg cells in homeostasis and disease—it’s all about the balance. Front Pharmacol. 2020;11:588436.

[14] Tan NH, Chen B, Peng J, Du S. Treg/Th17 cell balance in patients with hepatitis B virus-related acute-on-chronic liver failure at different disease stages. Biomed Res Int. 2021;2021:9140602.

[15] Bailey AL, Diamond MS. Hepatopathology of flaviviruses. J Hepatol. 2022;77(6):1711-1713.

[16] Pulendran B, Miller J, Querec TD, et al. e of yellow fever vaccine—associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes. J Infect Dis. 2008;198(4):500-507.

[17] Islam M, Kalita T, Saikia AK, et al. Significance of RANTES-CCR5 axis and linked downstream immunomodulation in Dengue pathogenesis: a study from Guwahati, India. J Med Virol. 2019;91(12):2066-2073.

[18] Carr JM, Cabezas-Falcon S, Dubowsky JG, Hulme-Jones J, Gordon DL. Dengue virus and the complement alternative pathway. FEBS Lett. 2020;594(16):2543-2555.

[19] Yang XO, Nurieva R, Martinez GJ, et al. Molecular antagonism and plasticity of regulatory and inflammatory T cell programs. Immunity. 2008;29(1):44-56.

[20] Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol. 2014;5:514.

[21] Ghita L, Yao Z, Xie Y, et al. Global and cell type-specific immunological hallmarks of severe dengue progression identified via a systems immunology approach. Nat Immunol. 2023;24(12):2150-2163.

[22] Schmidt A, Oberle N, Krammer PH. Molecular mechanisms of treg-mediated T cell suppression. Front Immunol. 2012;3:51.

[23] Lee JY, Hall JA, Kroehling L, et al. Serum amyloid a proteins induce pathogenic Th17 cells and promote inflammatory disease. Cell. 2020;180(1):79-91.e16.

[24] Zhang F, Wang H, Wang X, et al. TGF-β induces M2-like macrophage polarization via SNAIL-mediated suppression of a pro-inflammatory phenotype. Oncotarget. 2016;7(32):52294-52306.

RIGHTS & PERMISSIONS

2024 The Author(s). Animal Models and Experimental Medicine published by John Wiley & Sons Australia, Ltd on behalf of The Chinese Association for Laboratory Animal Sciences.